δ-Catenin peptide vaccines repress hepatocellular carcinoma growth via CD8(+) T cell activation

As classical therapy method of advanced hepatocellular carcinoma (HCC) is not effective enough, HCC immunotherapy is a hot spot for research in recent years. Although in recent years, immune checkpoint inhibitors are focused in cancer therapy, vaccines and adoptive cell therapy (ACT), as traditional...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoimmunology
Auteurs principaux: Huang, Fei, Chen, Junying, Lan, Ruilong, Wang, Zeng, Chen, Ruiqing, Lin, Jingan, Zhang, Lurong, Fu, Lengxi
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2018
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136873/
https://ncbi.nlm.nih.gov/pubmed/30221043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1450713
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires